CSX Corp: Form 10-Q for the period ended Sep 25, 2015
Filed with the SEC on Oct 14, 2015 and accepted by EDGAR at Oct 14, 2015, 16:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-09-25. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-06-27 to 2015-09-25 | $2.94bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months2014-12-27 to 2015-09-25 | $9.03bn | us-gaap:SalesRevenueNet |
| Operating income | 3 months2015-06-27 to 2015-09-25 | $933.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-12-27 to 2015-09-25 | $2.79bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-06-27 to 2015-09-25 | $136.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2014-12-27 to 2015-09-25 | $404.0m | us-gaap:InterestExpense |
| Income tax | 3 months2015-06-27 to 2015-09-25 | $292.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2014-12-27 to 2015-09-25 | $895.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-06-27 to 2015-09-25 | $507.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2014-12-27 to 2015-09-25 | $1.50bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-06-27 to 2015-09-25 | $0.52 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2014-12-27 to 2015-09-25 | $1.52 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-06-27 to 2015-09-25 | $0.52 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2014-12-27 to 2015-09-25 | $1.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-06-27 to 2015-09-25 | 982,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2014-12-27 to 2015-09-25 | 987,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-12-27 to 2015-09-25 | $2.51bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2014-12-27 to 2015-09-25 | $1.91bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2014-12-27 to 2015-09-25 | $512.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2015-06-27 to 2015-09-25 | $262.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Share repurchases | 9 months2014-12-27 to 2015-09-25 | $546.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-09-25 | $541.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-09-25 | $2.50bn | us-gaap:AssetsCurrent |
| Total assets | At period end2015-09-25 | $34.02bn | us-gaap:Assets |
| Current liabilities | At period end2015-09-25 | $1.92bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-09-25 | $22.36bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2015-09-25 | $11.66bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | At period end2015-09-25 | 974,944,791 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000277948-15-000039. Last ingested by Listed: Nov 4, 2026, 17:13 ET. Listed shows no prices and gives no investment advice.